Dearborn Partners’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Buy
12,022
+2,635
+28% +$66.4K 0.02% 240
2026
Q1
$237K Buy
9,387
+1,332
+17% +$34K 0.01% 246
2025
Q4
$206K Buy
+8,055
New +$206K 0.01% 257

Other funds holding IBDX

Dearborn Partners's IBDX Position: Q2 2026 in Review

Dearborn Partners increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 28% in Q2 2026, buying an estimated $66.4K and bringing the position to 12,022 shares worth $303K. The position accounts for 0.02% of the portfolio, ranked #240.

Dearborn Partners first reported a position in IBDX in Q4 2025 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Dearborn Partners held 12,022 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $303K as of Q2 2026.
  • Dearborn Partners bought 2,635 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $66.4K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.02% of Dearborn Partners's portfolio in Q2 2026, its #240 holding.
  • Dearborn Partners first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Dearborn Partners's 13F filing for Q2 2026, filed 13 Aug 2026.